Literature DB >> 9094636

Inflammatory cytokine expression is correlated with the level of human immunodeficiency virus (HIV) transcripts in HIV-infected placental trophoblastic cells.

B N Lee1, N Ordonez, E J Popek, J G Lu, A Helfgott, N Eriksen, H Hammill, C Kozinetz, M Doyle, M Kline, C Langston, W T Shearer, J M Reuben.   

Abstract

The inflammatory cytokines interleukin-1beta (IL-1beta), IL-6, and tumor necrosis factor alpha (TNF-alpha) have been associated with increased human immunodeficiency virus (HIV) expression and enhanced lymphocyte adhesion to trophoblastic cells in experimental systems. To determine if there is a correlation between the expression of these cytokines and the levels of HIV transcripts in trophoblasts of term placentas from HIV-infected women, we studied the placentae of 30 HIV-positive and 13 control gravidae. Twenty-three of the HIV-positive women received zidovudine (ZDV) as prophylaxis against HIV vertical transmission; only one of the seven women who did not receive ZDV was a transmitter, for an overall vertical transmission rate of 3.8%. Cytokine production was measured by enzyme-linked immunosorbent assay in the supernatants of trophoblastic cell cultures. Additionally, cytokine transcripts and HIV gag sequences were determined by a quantitative reverse transcription-PCR assay. In general, trophoblastic cells of HIV-positive placentas expressed significantly higher levels of IL-1beta, IL-6, and TNF-alpha than those of control placentas. All placentas from HIV-positive women expressed HIV gag transcripts at either a low (<156 copies per microg of total RNA) or a high (>156 copies per microg of total RNA) level. There was a statistically significant positive association between the basal level of TNF-alpha production and the level of HIV gag transcripts of HIV-positive placental trophoblastic cells. Nevertheless, these data, coupled with a low transmission rate, would indicate that some other factors, perhaps working in concert with cytokines, are necessary for vertical transmission of HIV from mother to infant.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9094636      PMCID: PMC191511     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  48 in total

1.  Purification, characterization, and in vitro differentiation of cytotrophoblasts from human term placentae.

Authors:  H J Kliman; J E Nestler; E Sermasi; J M Sanger; J F Strauss
Journal:  Endocrinology       Date:  1986-04       Impact factor: 4.736

2.  Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques: a comparison between ABC and unlabeled antibody (PAP) procedures.

Authors:  S M Hsu; L Raine; H Fanger
Journal:  J Histochem Cytochem       Date:  1981-04       Impact factor: 2.479

3.  Human immunodeficiency virus isolated from amniotic fluid.

Authors:  D C Mundy; R F Schinazi; A R Gerber; A J Nahmias; H W Randall
Journal:  Lancet       Date:  1987-08-22       Impact factor: 79.321

4.  Maternal-Fetal Transmission of Human Immunodeficiency Virus.

Authors:  N. Ahmad
Journal:  J Biomed Sci       Date:  1996 Jul-Aug       Impact factor: 8.410

5.  Effect of cytokines and anti-adhesion molecule antibodies on the adhesion of lymphocytic cells to human syncytiotrophoblast.

Authors:  G C Douglas; J Hu; T L Thirkill; K Hovanes; S Sharma; B F King
Journal:  J Reprod Immunol       Date:  1994-08       Impact factor: 4.054

Review 6.  The effect of cytokines and pharmacologic agents on chronic HIV infection.

Authors:  G Poli; A S Fauci
Journal:  AIDS Res Hum Retroviruses       Date:  1992-02       Impact factor: 2.205

7.  Use of the polymerase chain reaction for early detection of the proviral sequences of human immunodeficiency virus in infants born to seropositive mothers. New York City Collaborative Study of Maternal HIV Transmission and Montefiore Medical Center HIV Perinatal Transmission Study Group.

Authors:  M F Rogers; C Y Ou; M Rayfield; P A Thomas; E E Schoenbaum; E Abrams; K Krasinski; P A Selwyn; J Moore; A Kaul
Journal:  N Engl J Med       Date:  1989-06-22       Impact factor: 91.245

8.  Human immunodeficiency virus type 1 causes productive infection of macrophages in primary placental cell cultures.

Authors:  K A McGann; R Collman; D L Kolson; F Gonzalez-Scarano; G Coukos; C Coutifaris; J F Strauss; N Nathanson
Journal:  J Infect Dis       Date:  1994-04       Impact factor: 5.226

9.  Cell-mediated infection of human placental trophoblast with HIV in vitro.

Authors:  G C Douglas; G N Fry; T Thirkill; E Holmes; H Hakim; M Jennings; B F King
Journal:  AIDS Res Hum Retroviruses       Date:  1991-09       Impact factor: 2.205

10.  Epidermal growth factor inhibits cytokine-induced apoptosis of primary human trophoblasts.

Authors:  M I Garcia-Lloret; J Yui; B Winkler-Lowen; L J Guilbert
Journal:  J Cell Physiol       Date:  1996-05       Impact factor: 6.384

View more
  23 in total

1.  Up-regulation of CCR5 expression in the placenta is associated with human immunodeficiency virus-1 vertical transmission.

Authors:  H Behbahani; E Popek; P Garcia; J Andersson; A L Spetz; A Landay; Z Flener; B K Patterson
Journal:  Am J Pathol       Date:  2000-12       Impact factor: 4.307

2.  Impact of the placental cytokine-chemokine balance on regulation of cell-cell contact-induced human immunodeficiency virus type 1 translocation across a trophoblastic barrier in vitro.

Authors:  Muriel Derrien; Albert Faye; Guillermina Dolcini; Gérard Chaouat; Françoise Barré-Sinoussi; Elisabeth Menu
Journal:  J Virol       Date:  2005-10       Impact factor: 5.103

3.  Placental cytokine and chemokine production in HIV-1-infected women: trophoblast cells show a different pattern compared to cells from HIV-negative women.

Authors:  M Moussa; P Roques; N Fievet; E Menu; J G Maldonado-Estrada; J Brunerie; R Frydman; X Fritel; F Herve; G Chaouat
Journal:  Clin Exp Immunol       Date:  2001-09       Impact factor: 4.330

4.  Cytokine dysregulation in early- and late-term placentas from feline immunodeficiency virus (FIV)-infected cats.

Authors:  Veronica L Scott; Crystal E Boudreaux; Nikki N Lockett; Brittany T Clay; Karen S Coats
Journal:  Am J Reprod Immunol       Date:  2010-09-06       Impact factor: 3.886

5.  The trophoblastic epithelial barrier is not infected in full-term placentae of human immunodeficiency virus-seropositive mothers undergoing antiretroviral therapy.

Authors:  C Tscherning-Casper; N Papadogiannakis; M Anvret; L Stolpe; S Lindgren; A B Bohlin; J Albert; E M Fenyö
Journal:  J Virol       Date:  1999-11       Impact factor: 5.103

6.  Placental tumor necrosis factor alpha but not gamma interferon is associated with placental malaria and low birth weight in Malawian women.

Authors:  Stephen J Rogerson; Heidi C Brown; Elena Pollina; Elizabeth T Abrams; Eyob Tadesse; Valentino M Lema; Malcolm E Molyneux
Journal:  Infect Immun       Date:  2003-01       Impact factor: 3.441

Review 7.  Placental immunopathology in the FIV-infected cat: a role for inflammation in compromised pregnancy?

Authors:  Karen S Coats; Crystal E Boudreaux; Brittany T Clay; Nikki N Lockett; Veronica L Scott
Journal:  Vet Immunol Immunopathol       Date:  2009-10-14       Impact factor: 2.046

8.  Characterization of the main placental cytokine profiles from HIV-1-infected pregnant women treated with anti-retroviral drugs in France.

Authors:  A Faye; S Pornprasert; J-Y Mary; G Dolcini; M Derrien; F Barré-Sinoussi; G Chaouat; E Menu
Journal:  Clin Exp Immunol       Date:  2007-05-18       Impact factor: 4.330

9.  Higher Transplacental Pathogen-Specific Antibody Transfer Among Pregnant Women Randomized to Triple Antiretroviral Treatment Versus Short Course Zidovudine.

Authors:  Rose Bosire; Carey Farquhar; Ruth Nduati; Kristina Broliden; Stanley Luchters; Philippe Van de Perre; Isabelle De Vincenzi; Michele Merkel; Veronicah Wachuka; Dorothy Mbori-Ngacha; Grace John-Stewart; Barbara Lohman-Payne; Marie Reilly
Journal:  Pediatr Infect Dis J       Date:  2018-03       Impact factor: 2.129

10.  MicroRNome analysis unravels the molecular basis of SARS infection in bronchoalveolar stem cells.

Authors:  Bibekanand Mallick; Zhumur Ghosh; Jayprokas Chakrabarti
Journal:  PLoS One       Date:  2009-11-13       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.